oxocins - CISMeF

Preferred Label : oxocins;

MeSH definition : Compounds based on an 8-membered heterocyclic ring including an oxygen. They can be considered medium ring ethers.;

MeSH synonym : oxocenes;

Is substance : O;

Détails

Origin ID

D035964;

UMLS CUI

C1136100;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- brevetoxin receptor [MeSH Supplementary Concept]
Record concept(s)
- oxocins [MeSH concept]
Related MeSH Supplementary Concept(s)
- (12bR)-7,9-dimethoxy-3-methyl-1,2,3,7-tetrahydro-7,12b-methanobenzo(2,3)oxocino(5,4-c)pyridine [MeSH Supplementary Concept]
- 3-phenyl-1-(2,3,4,5-tetrahydro-1,6-benzodioxocin-8-yl)prop-2-en-1-one [MeSH Supplementary Concept]
- 41a-homoyessotoxin [MeSH Supplementary Concept]
- 9-methyl-41a-homoyessotoxin [MeSH Supplementary Concept]
- Brevetoxin A [MeSH Supplementary Concept]
- T34 toxin [MeSH Supplementary Concept]
- adriatoxin [MeSH Supplementary Concept]
- adriatoxin-B [MeSH Supplementary Concept]
- beta-naphthoylbrevetoxin [MeSH Supplementary Concept]
- brevetoxin [MeSH Supplementary Concept]
- brevetoxin 2 [MeSH Supplementary Concept]
- brevetoxin 3 [MeSH Supplementary Concept]
- brevetoxin 3, karenia brevis [MeSH Supplementary Concept]
- brevetoxin 7 [MeSH Supplementary Concept]
- brevetoxin B [MeSH Supplementary Concept]
- brevetoxin T17 [MeSH Supplementary Concept]
- brevetoxin-B2 [MeSH Supplementary Concept]
- brevisulcatic acid [MeSH Supplementary Concept]
- carboxyyessotoxin [MeSH Supplementary Concept]
- furanoyessotoxin [MeSH Supplementary Concept]
- gambierol [MeSH Supplementary Concept]
- glycoyessotoxin [MeSH Supplementary Concept]
- isolaurallene [MeSH Supplementary Concept]
- isolaureatin [MeSH Supplementary Concept]
- laurallene [MeSH Supplementary Concept]
- laurencin [MeSH Supplementary Concept]
- maitotoxin [MeSH Supplementary Concept]
- prelaureatin [MeSH Supplementary Concept]
- protosappanin B [MeSH Supplementary Concept]
- ptychodiscus brevis T2 toxin [MeSH Supplementary Concept]
- tamulamide A [MeSH Supplementary Concept]
- tamulamide B [MeSH Supplementary Concept]
- yessotoxin [MeSH Supplementary Concept]
- yessotoxin 32-O-(beta-L-arabinofuranosyl-(5'-1'')-beta-L-arabinofuranoside), protoceratium reticulatum [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients